Interventions to decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin (5-HT3) receptor antagonists: a systematic review

BACKGROUND: Patients may experience nausea and vomiting when undergoing chemotherapy or surgery requiring anesthesia. Serotonin 5-hydroxytryptamine 3 (5-HT3) receptor antagonists are effective antiemetics, yet may cause adverse cardiac events, such as arrhythmia. We aimed to identify interventions t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tricco, Andrea C, Soobiah, Charlene, Hui, Wing, Antony, Jesmin, Struchkov, Vladi, Hutton, Brian, Hemmelgarn, Brenda, Moher, David, Straus, Sharon E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417335/
https://www.ncbi.nlm.nih.gov/pubmed/25623303
http://dx.doi.org/10.1186/2050-6511-16-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417335/
https://www.ncbi.nlm.nih.gov/pubmed/25623303
http://dx.doi.org/10.1186/2050-6511-16-1

Ejemplares similares